TABLE 5.
Serum vibriocidal titers of convalescent sera from patients infected with V. cholerae O139 measured before and after absorption with CPS or treatment with 2-ME
| Patient | Vibriocidal titera
|
||
|---|---|---|---|
| Untreated | CPS absorbed | 2-ME treated | |
| SK 391-2 | 3,200 | <50 | <50 |
| SK 395-2 | 1,600 | <50 | <50 |
| SK 428-2 | 800 | <50 | <50 |
| SK 456-2 | 400 | <50 | <50 |
| SK 458-2 | 3,200 | <50 | <50 |
| SK 494-2 | 100 | <50 | <50 |
| SK 504-2 | 400 | <50 | <50 |
| SK 522-2 | 1,600 | <50 | 50 |
| SK 577-2 | 1,600 | <50 | <50 |
| SK 591-2 | 1,600 | <50 | <50 |
| SK 597-2 | 800 | <50 | <50 |
| SK 599-2 | 3,200 | <50 | <50 |
| SK 622-2 | 400 | <50 | 50 |
| SK 639-2 | 400 | <50 | 400 |
| SK 646-2 | 3,200 | <50 | <50 |
| SK 720-2 | 1,600 | <50 | <50 |
| SK 741-2 | 800 | <50 | <50 |
| SK 749-2 | >6,400 | 50 | 100 |
| SK 755-2 | 1,600 | <50 | 200 |
| SK 760-2 | 1,600 | <50 | 50 |
Each vibriocidal assay was performed with twofold serially diluted tested serum starting from a 1:50 dilution and using V. cholerae O139 SPH1168 as the target strain.